Excessive Daytime Sleepiness
&nbsp;
Excessive Daytime Sleepiness (EDS) is characterized by difficulty in staying awake and alert during the major waking episodes of the day, with sleep occurring unintentionally or at inappropriate times of the wake period.
Excessive Daytime Sleepiness is often associated with a wide range of illnesses, including metabolic, cardiovascular, neurological, and psychiatric diseases but also with voluntary behaviors reflecting poor sleep and sleep debt, leading to disability and increased mortality risk.
&nbsp;
Excessive Daytime Sleepiness Epidemiology Segmentation in the 7MM
&nbsp;
●&nbsp; &nbsp; Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness
● &nbsp; Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/excessive-daytime-sleepiness-eds-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Excessive Daytime Sleepiness Epidemiological Insights</a> Observed in the 7MM
(2021)
&nbsp;
<ul>
<li class="ql-align-justify">The total incident cases of Excessive Daytime Sleepiness observed in the 7MM were observed to be 6.8 Million in the year 2021</li>
<li class="ql-align-justify">The highest diagnosed Excessive Daytime Sleepiness population accounting for 3.7 million cases, was found in the United States in the year 2021</li>
<li class="ql-align-justify">EU5 accounted for 2 million cases, whereas Japan accounted for the lowest number of cases, i.e., 1 million cases.&nbsp;</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/excessive-daytime-sleepiness-eds-market" target="_blank" rel="noopener noreferrer">Excessive Daytime Sleepiness Market Insight</a>
&nbsp;
<ul>
<li class="ql-align-justify">The market size of Excessive Daytime Sleepiness in the 7MM was found to be approximately USD 4,946 Million in 2021. &nbsp;</li>
<li class="ql-align-justify">The market size of Excessive Daytime Sleepiness in the United States was found to be approximately USD 4,946 Million in 2021. &nbsp;</li>
<li class="ql-align-justify">In EU5, the market size of Excessive Daytime Sleepiness was found to be USD 1,186 million, whereas that of Japan was approximately USD 361 million.&nbsp;</li>
</ul>
&nbsp;
Excessive Daytime Sleepiness Market Strengths
&nbsp;
The rise in the prevalence of associated conditions such as Parkinson's disease, OSA, narcolepsy, etc. might contribute to an increase in the patient population of EDS&nbsp;
Excessive Daytime Sleepiness Market Opportunities
&nbsp;
Most of the approved therapies are developed for daily intake. Hence medications with longer effectiveness are the current unmet need of the EDS market.
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/excessive-daytime-sleepiness-pipeline-insights" target="_blank" rel="noopener noreferrer">Excessive Daytime Sleepiness Emerging Drugs</a>
The emerging drugs in the Excessive Daytime Sleepiness market are
<ul>
<li class="ql-align-justify">FT218 (Sodium Oxybate):</li>
<li class="ql-align-justify">AXS-12 (Reboxetine)</li>
<li class="ql-align-justify">THN102 (Flecainide and Modafinil)</li>
<li class="ql-align-justify">Samelisant (SUVN-G3031)</li>
<li class="ql-align-justify">Quilience (Mazindol Extended-release/NLS-2)</li>
<li class="ql-align-justify">XW10172</li>
<li class="ql-align-justify">TAK-994 and others</li>
</ul>
&nbsp;
&nbsp;
Excessive Daytime Sleepiness Key Players&nbsp;
&nbsp;
The key players working in the Excessive Daytime Sleepiness market are
&nbsp;
<ul>
<li class="ql-align-justify">Avadel Pharmaceutical</li>
<li class="ql-align-justify">Axsome Therapeutic</li>
<li class="ql-align-justify">Theranexus</li>
<li class="ql-align-justify">Suven Life Sciences</li>
<li class="ql-align-justify">NLS Pharma Ltd</li>
<li class="ql-align-justify">XWPharma&nbsp;</li>
<li>Takeda Pharmaceutical, and others</li>
</ul>

Excessive Daytime Sleepiness

Excessive Daytime Sleepiness Market

 Excessive Daytime Sleepiness Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape